Jim Simons F Star Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$4.09 - $6.86 $202,864 - $340,256	-49,600 Reduced 22.39%	171,911 $1.09 Million
Q3 2022 Nov 14, 2022	BUY	$5.41 - $6.74 $292,681 - $364,634	54,100 Added 32.32%	221,511 $1.13 Million
Q2 2022 Aug 12, 2022	SELL	$2.18 - $6.39 $178,169 - $522,248	-81,729 Reduced 32.8%	167,411 $1.05 Million
Q1 2022 May 13, 2022	SELL	$2.77 - $5.36 $111,550 - $215,852	-40,271 Reduced 13.91%	249,140 $884,000
Q4 2021 Feb 11, 2022	BUY	$4.71 - $7.38 $800,700 - $1.25 Million	170,000 Added 142.37%	289,411 $1.45 Million
Q3 2021 Nov 12, 2021	SELL	$5.2 - $8.42 $143,520 - $232,392	-27,600 Reduced 18.77%	119,411 $874,000
Q2 2021 Aug 13, 2021	BUY	$6.57 - $10.71 $57,159 - $93,177	8,700 Added 6.29%	147,011 $1.26 Million
Q1 2021 May 13, 2021	SELL	$7.09 - $13.84 $308,259 - $601,735	-43,478 Reduced 23.92%	138,311 $1.5 Million
Q4 2020 Feb 10, 2021	BUY	$1.03 - $10.39 $187,242 - $1.89 Million	181,789 New	181,789 $1.79 Million

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.